Our JUNE ISSUE is live! Therapeutic targets for MASH, metabotherapy for intestinal disease, germiline mutations and somatic mosaicism in SLD-related liver cancer, artificial intelligence in IBD, and much more! www.nature.com/nrgastro/vol...
Katrina Ray
@heykatray.bsky.social
Science, music, trashy TV & tap-dancing | Chief Ed - Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.bsky.social | Opinions own | she/her/they | #LiverSky #gastrosky #gisky #MicroSky
All things gut health take centre stage in our May issue 👇 Beautiful cover by our Art Editor Laura Marshall, I find it somewhat hypnotic and soothing #gastrosky #liversky #microsky
Our MAY ISSUE is live! Consensus statement on gut health, dietary proteins and colonic disease, cholesterol metabolism, acute-on-chronic liver failure, and much more! www.nature.com/nrgastro/vol...
This new review from Core Investigator @christophthaiss.bsky.social & Innovation Investigator @maayanlevy.bsky.social maps how gut metabolites shape diseases from IBD to cancer, and lays out a framework for using them as therapies.
New online! Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut
As a virome and phageome scientist, I highly recommend this article. Happy holiday season, everyone!🎉
And what a cracking set of covers they are! We have phenomenal Art editors working with us 🎨🖌️🖼️
It is time for a well-deserved break for the Editorial team over the holidays - the editorial office will be closed from now until 5th January 🎄🎁☃️ Thanks to all our authors, referees and readers, it's been a fantastic year. Check out our wonderful covers! www.nature.com/nrgastro/vol... #gastrosky
Our December issue is out! #liversky #gastrosky. Featuring a great cover by Richard Tibbitts inspired by the ‘Jekyll and Hyde’ roles of memory T cells
Our DECEMBER ISSUE is live! Hepatic T cells, microbiome and pancreatic cancer, portal hypertension and cirrhosis, metabolic and alcohol-related liver disease and much more! www.nature.com/nrgastro/vol...
We’re seeking public feedback on newly proposed quality indicators for #IBD care — designed to promote evidence-based, consistent care for #CrohnsDisease & #UlcerativeColitis patients. 🗓️ Submit your feedback by Nov. 29: gastro.org/news/open-fo... #GISky
New issue out! #gastrosky #liversky
Our NOVEMBER ISSUE introducing our new Series of articles on NUTRITION is live! Intestinal mucosa, parental diet and offspring health, LLMs and clinical decision, AI and microbiome, and much more! www.nature.com/nrgastro/vol...
SOOOOO excited to see this online IN REAL-LIFE!! Here, we review the latest in hepatic tissue-resident #Tcell biology. We draw on a metaphor proposed by Robert Louis Stevenson [1886] to highlight the fact a cell can manifest different behaviours & actions depending on environmental context 🧪
New online! Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment
Our new @natrevgastrohep.nature.com review is now online "Parental diet and offspring health: a role for the gut microbiome via epigenetics" Co-authors Chaoran Yang, @mattsnelson.bsky.social & Sam El-Osta A fascinating area of research with lots of potential nature.com/articles/s41...
New issue out now! Check it out, including an interesting article about the oesophagus as an immune organ #gastrosky #liversky #hepsky #medsky #microsky
Our SEPTEMBER ISSUE is live! CRC health disparities, gut microbiome in MASLD, intestinal pH, oesophagus immunology, and much more! www.nature.com/nrgastro/vol...
A Review in Nature Reviews Gastroenterology & Hepatology discusses how diet shapes the gut #microbiome, the role of diet–microbiome interactions on the immune, nervous and cardiometabolic systems, and implications for dietary guidelines and precision nutrition. go.nature.com/41F8baD #medsky 🧪
Great to see our Review "The gut microbiome connects nutrition and human health" making the cover of this month's @natrevgastrohep.nature.com @patrickveiga.bsky.social @eranelinav.bsky.social www.nature.com/articles/s41...
Cracking new issue out now! And a great cover drawn many Neil Smith, I really want a gut chopping board now! #gastrosky
Our August issue is live! Gut microbiome & nutrition, menopause & gastrointestinal health, alcohol-related liver disease, enteric nervous system & much more! www.nature.com/nrgastro/vol... #gastrosky #liversky #microsky
Fascinating paper in @lancetgastrohep.bsky.social - The expectation of eating gluten/wheat played a major part in symptoms "IBS patients with self-perceived gluten sensitivity reacted similarly to gluten, wheat, and sham challenges" www.thelancet.com/journals/lan... #gastrosky
Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial
IBS patients with self-perceived gluten sensitivity reacted similarly to gluten, wheat, and sham challenges. These findings suggest that expectations played a major role in symptom generation, and tha...
thelancet.com
🧪
So great to see this labor of love published! 👉🏾 rdcu.be/exb0r Honored to work w/ #SamirGupta, #WintaMehtsun, & #AhmedinJemal on a comprehensive overview of Black–White #disparities across the #CRC continuum in the US @natrevgastrohep.nature.com @nature.com #colorectalcancer @dgsomucla.bsky.social
🧪
The esophagus has been viewed as a simple tube for food. We present evidence that the esophagus is an immune organ with extensive sensing properties designed to tolerate and mount defenses against antigenic and biophysical challenges. rdcu.be/eueRE @natrevgastrohep.nature.com
It's #worldmicrobiomeday and we love the gut #microbiome so let's celebrate with some of our recent #microbiota articles 🦠💩 #gastrosky #microsky #microbiomesky #gastrosky
New online! Lessons from incretin-based therapy in MASH and obesity
Lessons from incretin-based therapy in MASH and obesity
Nature Reviews Gastroenterology & Hepatology, Published online: 27 June 2025; doi:10.1038/s41575-025-01096-2Glucagon-like peptide 1 receptor agonists are effective pharmacotherapies for the treatment of obesity and related disorders. In metabolic dysfunction-associated steatohepatitis with moderate to advanced fibrosis, semaglutide improved liver histology over 72 weeks. In another new study, tirzepatide was superior to semaglutide in reducing body weight in individuals with obesity.
nature.com
🚨 attention all early career researchers! Check out this new award, details below Super excited to be on the judging panel for the gastrointestinal and inflammatory diseases section #gastrosky #liversky 🧪
Applications are now open for the 2026 Takeda Innovators in Science Award with Nature. Early-career researchers in GI & inflammatory disease, neuroscience or oncology: Win a share of US$400K and earn global recognition. Apply today: go.nature.com/4jBp3oM #Academicsky